Transfection of Antisense Oligodeoxynucleotide Inhibits Heparanase Gene Expression and Invasive Ability of Human Pancreatic Cancer Cell in vitro

Extracellular matrix (ECM) degradation is an essential step that allows tumor cells to penetrate a tissue barrier and become metastatic. Heparanase (HPSE) is an endoglycosidase that specifically degrades heparin sulfate proteoglycans (HSPG), a chief component of ECM, HPSE is not expressed in normal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Huazhong University of Science and Technology. Medical sciences 2006, Vol.26 (1), p.72-74
1. Verfasser: 高军 苏琳 秦仁义 常青 黄涛 冯延平
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 74
container_issue 1
container_start_page 72
container_title Journal of Huazhong University of Science and Technology. Medical sciences
container_volume 26
creator 高军 苏琳 秦仁义 常青 黄涛 冯延平
description Extracellular matrix (ECM) degradation is an essential step that allows tumor cells to penetrate a tissue barrier and become metastatic. Heparanase (HPSE) is an endoglycosidase that specifically degrades heparin sulfate proteoglycans (HSPG), a chief component of ECM, HPSE is not expressed in normal epithelial cells but can be detected in a variety of human carcinomas including pancreatic cancer. In the present study, human pancreatic cancer cell line Panc-1 was transfected with HPSE antisense oligodeoxynucleotide (AS-ODN) in vitro, then the inhibitory effect of ASODN on HPSE gene expression and invasive ability of Panc-1 cells in vitro was examined. The HPSE mRNA and protein expression of Panc-1 cells transfected with AS-ODN was significantly inhibited. However, there were no marked inhibitory effects in Panc-1 cells treated with nonsense oligodeoxynucleotide (NS-ODN). Moreover, a modified Boyden chamber assay demonstrated that transfection with HPSE AS-ODN significantly inhibited invasive potential of Panc-1 cells in vitro after AS-ODN transfection. This suggests that HPSE AS-ODN may contribute to the inhibition of HPSE mRNA and protein expression, and results in a decrease of the invasive ability of Panc-1 in vitro.
doi_str_mv 10.1007/bf02828042
format Article
fullrecord <record><control><sourceid>wanfang_jour_proqu</sourceid><recordid>TN_cdi_wanfang_journals_tjykdxxb_e200601020</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>21351332</cqvip_id><wanfj_id>tjykdxxb_e200601020</wanfj_id><sourcerecordid>tjykdxxb_e200601020</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2180-54882629a7ae29a5025f8f9991cde65495b057043262fc3201e75dc57da495da3</originalsourceid><addsrcrecordid>eNqF0cFuGyEQANBV1apJ0176ARXqoZdo2wGWZTlaVhpHipQe0vOKhcHBWYMDu679F_3kEDk99wIjzWNm0FTVZwrfKYD8MThgHeugYW-qc6oUrykX7G2JW8lqkJyfVR9y3gAI2bLmfXVWEpQCZefV3_ukQ3ZoJh8DiY4swuQzhozkbvTraDEejmE2I8bJWyQ34cEPfspkhTtdnuoCrzEguTrsEub8UkUHW9xeZ79Hshj86KfjS-nVvNWB_NLBJNSTN2RZQkxkieNIfCB7P6X4sXrn9Jjx0-t9Uf3-eXW_XNW3d9c3y8VtbRjtoBZN17GWKS01llMAE65zSilqLLaiUWIov4WGF-QMZ0BRCmuEtLrkrOYX1eWp7h8dnA7rfhPnFErHftocH-3hMPTIAFqgwKDobye9S_Fpxjz1W59NmVsHjHPuW6kUA9X9F1IlOykaUeCXVzgPW7T9LvmtTsf-32oK-HoC5iGG9ZMvIw7aPDo_Ys_KginnjD8DUx2bpQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19787545</pqid></control><display><type>article</type><title>Transfection of Antisense Oligodeoxynucleotide Inhibits Heparanase Gene Expression and Invasive Ability of Human Pancreatic Cancer Cell in vitro</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>高军 苏琳 秦仁义 常青 黄涛 冯延平</creator><creatorcontrib>高军 苏琳 秦仁义 常青 黄涛 冯延平</creatorcontrib><description>Extracellular matrix (ECM) degradation is an essential step that allows tumor cells to penetrate a tissue barrier and become metastatic. Heparanase (HPSE) is an endoglycosidase that specifically degrades heparin sulfate proteoglycans (HSPG), a chief component of ECM, HPSE is not expressed in normal epithelial cells but can be detected in a variety of human carcinomas including pancreatic cancer. In the present study, human pancreatic cancer cell line Panc-1 was transfected with HPSE antisense oligodeoxynucleotide (AS-ODN) in vitro, then the inhibitory effect of ASODN on HPSE gene expression and invasive ability of Panc-1 cells in vitro was examined. The HPSE mRNA and protein expression of Panc-1 cells transfected with AS-ODN was significantly inhibited. However, there were no marked inhibitory effects in Panc-1 cells treated with nonsense oligodeoxynucleotide (NS-ODN). Moreover, a modified Boyden chamber assay demonstrated that transfection with HPSE AS-ODN significantly inhibited invasive potential of Panc-1 cells in vitro after AS-ODN transfection. This suggests that HPSE AS-ODN may contribute to the inhibition of HPSE mRNA and protein expression, and results in a decrease of the invasive ability of Panc-1 in vitro.</description><identifier>ISSN: 1672-0733</identifier><identifier>EISSN: 1993-1352</identifier><identifier>DOI: 10.1007/bf02828042</identifier><identifier>PMID: 16711012</identifier><language>eng</language><publisher>China: Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China%Department of Internal Medicine, Zichuan Hospital, Zibo 255100, China</publisher><subject>Cell Line, Tumor ; Extracellular Matrix - metabolism ; Glucuronidase - biosynthesis ; Glucuronidase - genetics ; Humans ; Neoplasm Invasiveness ; Oligonucleotides, Antisense - genetics ; Oligonucleotides, Antisense - pharmacology ; Pancreatic Neoplasms - enzymology ; Pancreatic Neoplasms - genetics ; Pancreatic Neoplasms - pathology ; RNA, Messenger - biosynthesis ; RNA, Messenger - genetics ; 基因表达 ; 基因转染 ; 病理机制 ; 胰腺肿瘤</subject><ispartof>Journal of Huazhong University of Science and Technology. Medical sciences, 2006, Vol.26 (1), p.72-74</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/85740A/85740A.jpg</thumbnail><link.rule.ids>314,776,780,4009,27902,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16711012$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>高军 苏琳 秦仁义 常青 黄涛 冯延平</creatorcontrib><title>Transfection of Antisense Oligodeoxynucleotide Inhibits Heparanase Gene Expression and Invasive Ability of Human Pancreatic Cancer Cell in vitro</title><title>Journal of Huazhong University of Science and Technology. Medical sciences</title><addtitle>Journal of Zuazhong University of Science and Technology: Medical Edition</addtitle><description>Extracellular matrix (ECM) degradation is an essential step that allows tumor cells to penetrate a tissue barrier and become metastatic. Heparanase (HPSE) is an endoglycosidase that specifically degrades heparin sulfate proteoglycans (HSPG), a chief component of ECM, HPSE is not expressed in normal epithelial cells but can be detected in a variety of human carcinomas including pancreatic cancer. In the present study, human pancreatic cancer cell line Panc-1 was transfected with HPSE antisense oligodeoxynucleotide (AS-ODN) in vitro, then the inhibitory effect of ASODN on HPSE gene expression and invasive ability of Panc-1 cells in vitro was examined. The HPSE mRNA and protein expression of Panc-1 cells transfected with AS-ODN was significantly inhibited. However, there were no marked inhibitory effects in Panc-1 cells treated with nonsense oligodeoxynucleotide (NS-ODN). Moreover, a modified Boyden chamber assay demonstrated that transfection with HPSE AS-ODN significantly inhibited invasive potential of Panc-1 cells in vitro after AS-ODN transfection. This suggests that HPSE AS-ODN may contribute to the inhibition of HPSE mRNA and protein expression, and results in a decrease of the invasive ability of Panc-1 in vitro.</description><subject>Cell Line, Tumor</subject><subject>Extracellular Matrix - metabolism</subject><subject>Glucuronidase - biosynthesis</subject><subject>Glucuronidase - genetics</subject><subject>Humans</subject><subject>Neoplasm Invasiveness</subject><subject>Oligonucleotides, Antisense - genetics</subject><subject>Oligonucleotides, Antisense - pharmacology</subject><subject>Pancreatic Neoplasms - enzymology</subject><subject>Pancreatic Neoplasms - genetics</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>RNA, Messenger - biosynthesis</subject><subject>RNA, Messenger - genetics</subject><subject>基因表达</subject><subject>基因转染</subject><subject>病理机制</subject><subject>胰腺肿瘤</subject><issn>1672-0733</issn><issn>1993-1352</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0cFuGyEQANBV1apJ0176ARXqoZdo2wGWZTlaVhpHipQe0vOKhcHBWYMDu679F_3kEDk99wIjzWNm0FTVZwrfKYD8MThgHeugYW-qc6oUrykX7G2JW8lqkJyfVR9y3gAI2bLmfXVWEpQCZefV3_ukQ3ZoJh8DiY4swuQzhozkbvTraDEejmE2I8bJWyQ34cEPfspkhTtdnuoCrzEguTrsEub8UkUHW9xeZ79Hshj86KfjS-nVvNWB_NLBJNSTN2RZQkxkieNIfCB7P6X4sXrn9Jjx0-t9Uf3-eXW_XNW3d9c3y8VtbRjtoBZN17GWKS01llMAE65zSilqLLaiUWIov4WGF-QMZ0BRCmuEtLrkrOYX1eWp7h8dnA7rfhPnFErHftocH-3hMPTIAFqgwKDobye9S_Fpxjz1W59NmVsHjHPuW6kUA9X9F1IlOykaUeCXVzgPW7T9LvmtTsf-32oK-HoC5iGG9ZMvIw7aPDo_Ys_KginnjD8DUx2bpQ</recordid><startdate>2006</startdate><enddate>2006</enddate><creator>高军 苏琳 秦仁义 常青 黄涛 冯延平</creator><general>Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China%Department of Internal Medicine, Zichuan Hospital, Zibo 255100, China</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QO</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope></search><sort><creationdate>2006</creationdate><title>Transfection of Antisense Oligodeoxynucleotide Inhibits Heparanase Gene Expression and Invasive Ability of Human Pancreatic Cancer Cell in vitro</title><author>高军 苏琳 秦仁义 常青 黄涛 冯延平</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2180-54882629a7ae29a5025f8f9991cde65495b057043262fc3201e75dc57da495da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Cell Line, Tumor</topic><topic>Extracellular Matrix - metabolism</topic><topic>Glucuronidase - biosynthesis</topic><topic>Glucuronidase - genetics</topic><topic>Humans</topic><topic>Neoplasm Invasiveness</topic><topic>Oligonucleotides, Antisense - genetics</topic><topic>Oligonucleotides, Antisense - pharmacology</topic><topic>Pancreatic Neoplasms - enzymology</topic><topic>Pancreatic Neoplasms - genetics</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>RNA, Messenger - biosynthesis</topic><topic>RNA, Messenger - genetics</topic><topic>基因表达</topic><topic>基因转染</topic><topic>病理机制</topic><topic>胰腺肿瘤</topic><toplevel>online_resources</toplevel><creatorcontrib>高军 苏琳 秦仁义 常青 黄涛 冯延平</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><jtitle>Journal of Huazhong University of Science and Technology. Medical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>高军 苏琳 秦仁义 常青 黄涛 冯延平</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transfection of Antisense Oligodeoxynucleotide Inhibits Heparanase Gene Expression and Invasive Ability of Human Pancreatic Cancer Cell in vitro</atitle><jtitle>Journal of Huazhong University of Science and Technology. Medical sciences</jtitle><addtitle>Journal of Zuazhong University of Science and Technology: Medical Edition</addtitle><date>2006</date><risdate>2006</risdate><volume>26</volume><issue>1</issue><spage>72</spage><epage>74</epage><pages>72-74</pages><issn>1672-0733</issn><eissn>1993-1352</eissn><abstract>Extracellular matrix (ECM) degradation is an essential step that allows tumor cells to penetrate a tissue barrier and become metastatic. Heparanase (HPSE) is an endoglycosidase that specifically degrades heparin sulfate proteoglycans (HSPG), a chief component of ECM, HPSE is not expressed in normal epithelial cells but can be detected in a variety of human carcinomas including pancreatic cancer. In the present study, human pancreatic cancer cell line Panc-1 was transfected with HPSE antisense oligodeoxynucleotide (AS-ODN) in vitro, then the inhibitory effect of ASODN on HPSE gene expression and invasive ability of Panc-1 cells in vitro was examined. The HPSE mRNA and protein expression of Panc-1 cells transfected with AS-ODN was significantly inhibited. However, there were no marked inhibitory effects in Panc-1 cells treated with nonsense oligodeoxynucleotide (NS-ODN). Moreover, a modified Boyden chamber assay demonstrated that transfection with HPSE AS-ODN significantly inhibited invasive potential of Panc-1 cells in vitro after AS-ODN transfection. This suggests that HPSE AS-ODN may contribute to the inhibition of HPSE mRNA and protein expression, and results in a decrease of the invasive ability of Panc-1 in vitro.</abstract><cop>China</cop><pub>Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China%Department of Internal Medicine, Zichuan Hospital, Zibo 255100, China</pub><pmid>16711012</pmid><doi>10.1007/bf02828042</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1672-0733
ispartof Journal of Huazhong University of Science and Technology. Medical sciences, 2006, Vol.26 (1), p.72-74
issn 1672-0733
1993-1352
language eng
recordid cdi_wanfang_journals_tjykdxxb_e200601020
source MEDLINE; Alma/SFX Local Collection
subjects Cell Line, Tumor
Extracellular Matrix - metabolism
Glucuronidase - biosynthesis
Glucuronidase - genetics
Humans
Neoplasm Invasiveness
Oligonucleotides, Antisense - genetics
Oligonucleotides, Antisense - pharmacology
Pancreatic Neoplasms - enzymology
Pancreatic Neoplasms - genetics
Pancreatic Neoplasms - pathology
RNA, Messenger - biosynthesis
RNA, Messenger - genetics
基因表达
基因转染
病理机制
胰腺肿瘤
title Transfection of Antisense Oligodeoxynucleotide Inhibits Heparanase Gene Expression and Invasive Ability of Human Pancreatic Cancer Cell in vitro
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T10%3A31%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transfection%20of%20Antisense%20Oligodeoxynucleotide%20Inhibits%20Heparanase%20Gene%20Expression%20and%20Invasive%20Ability%20of%20Human%20Pancreatic%20Cancer%20Cell%20in%20vitro&rft.jtitle=Journal%20of%20Huazhong%20University%20of%20Science%20and%20Technology.%20Medical%20sciences&rft.au=%E9%AB%98%E5%86%9B%20%E8%8B%8F%E7%90%B3%20%E7%A7%A6%E4%BB%81%E4%B9%89%20%E5%B8%B8%E9%9D%92%20%E9%BB%84%E6%B6%9B%20%E5%86%AF%E5%BB%B6%E5%B9%B3&rft.date=2006&rft.volume=26&rft.issue=1&rft.spage=72&rft.epage=74&rft.pages=72-74&rft.issn=1672-0733&rft.eissn=1993-1352&rft_id=info:doi/10.1007/bf02828042&rft_dat=%3Cwanfang_jour_proqu%3Etjykdxxb_e200601020%3C/wanfang_jour_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19787545&rft_id=info:pmid/16711012&rft_cqvip_id=21351332&rft_wanfj_id=tjykdxxb_e200601020&rfr_iscdi=true